Gregor Vlasak

Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com

Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com

Perella Weinberg is a leading global independent financial services firm, founded in 2006 to address the need for experienced, trusted and unconflicted advice in the financial services sector. Our collaborative team of bankers, with broad and deep industry expertise delivers novel insights, differentiated guidance, and tailored solutions for our clients. Our bankers’ extensive and unparalleled advisory experience enables us to assist our clients as they navigate opportunities and challenges in any market environment. For more information visit www.pwpartners.com.

As one of the world’s leading exchange organisations, Deutsche Börse Group provides investors, financial institutions and companies access to global capital markets. Our business covers the entire financial market transaction process chain, ranging from securities and derivatives trading, clearing, settlement and custody, to market data and the development and operation of electronic trading systems. As a technology company, we develop state-of-the-art IT solutions and offer IT systems all over the world. Our reliable systems and our integrity as a neutral market infrastructure provider form the basis of our business philosophy. We operate to the most exacting standards to create products and services which meet the needs of international financial markets. As a listed company we work to create value for our customers and our shareholders. Privacy notice: https://deutsche-boerse.com/social-media-privacy Imprint: https://deutsche-boerse.com/imprint